Skip to main content

GEODE CAPITAL MANAGEMENT, LLC

Position in KROS — Keros Therapeutics, Inc.

CIK 1214717 BOSTON, MA

Position in KROS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$5,465,998
-$2,057,319 QoQ
Shares Held
510,841
-25.0% QoQ
Ownership
2.58%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 132 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KROS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. KROS ranks #229 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KROS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,465,998 510,841
2026-03-31 $7,523,317 681,460
2025-12-31 $12,932,834 635,208
2025-09-30 $13,247,081 837,363
2025-06-30 $11,071,114 829,297
2025-03-31 $8,215,024 806,185
2024-12-31 $12,116,851 765,436
2024-09-30 $42,136,810 725,621
2024-06-30 $31,056,805 679,580
2024-03-31 $39,445,005 595,846
2023-12-31 $20,285,989 510,211
2023-09-30 $15,493,711 486,001
2023-06-30 $16,904,609 420,722
2023-03-31 $15,715,564 368,046
2022-12-31 $16,794,898 349,748
2022-09-30 $11,893,525 316,149
2022-06-30 $7,595,542 274,902
2022-03-31 $14,945,962 274,843
2021-12-31 $14,963,756 255,747
2021-09-30 $8,418,605 212,806
2021-06-30 $9,365,781 220,527
2021-03-31 $10,710,992 174,021
2020-12-31 $11,107,228 157,460
2020-09-30 $4,243,779 110,028
2020-06-30 $4,022,122 107,228